期刊文献+

肺炎型肺癌的诊治体会(附10例报道) 被引量:3

Diagnosis and Treatment of Pneumonic-type Lung Carcinoma ( Report of 10 Cases)
下载PDF
导出
摘要 目的:探讨肺炎型肺癌(PTLC)的临床特点及诊断和治疗。方法:回顾性分析我院2004年3月至2009年10月期间收治的10例PTLC患者的临床资料,对其诊断和治疗进行分析。结果:PTLC缺乏特异性临床表现,影像学表现为大片状实变伴"空气支气管征"、"空泡征"及小结节等,确诊需有病理学结果。10例患者均行手术治疗,行根治性手术7例,其中肺叶切除4例,联合肺叶切除1例,一侧肺切除2例,3例患者因肿瘤广泛转移而仅行剖胸活检术。围手术期无死亡和严重并发症发生。术后辅以化疗或放疗。经4个月~60个月随访,其中3例丧失手术机会者于术后1年内全部死于呼吸衰竭,7例患者生存期为15个月~52个月(平均31个月)。结论:PTLC早期诊断需结合临床表现和影像学检查,病理学检查可确诊。手术是治疗的主要手段。 Objective: To explore the diagnosis and treatment of pneumonic-type lung carcinoma (PTLC). Methods: The clinical data of 10 patients with PTLC were retrospectively collected. The diagnosis and treatment were analyzed. Results: The patients with PTLC lacked typical clinical manifestations. The characteristic imaging findings included massive consolidation accompanied with air bronchogram, vacuole sign and small nodules. Pathologic finding was indispensable to diagnosis. Surgery was performed in all patients. Seven patients underwent radical operation including pulmonary lobectomy in 4 cases, bilobectomy in one case and lobectomy in two cases, the rest 3 cases only received biopsy through thoracotomy due to extensive metastasis. No one died and no serious complication happened during operation. The patients received chemotherapy or radiotherapy after operation. After the follow-up of 3 - 60 months, 3 cases who could not be radically resected died of respiratory failure after one year of operation and 7 cases survived from 15 to 52 months (mean 31 months). Conclusion: Early diagnosis of PTLC depends on clinical manifestation and imaging examination. Pathological examination is used to confirm the diagnosis. Surgery is the main method to cure this disease.
作者 李伟
出处 《肿瘤预防与治疗》 2010年第6期500-502,共3页 Journal of Cancer Control And Treatment
关键词 肺炎型肺癌 诊断 治疗 手术 Pneumonic-type Lung Carcinoma Diagnosis Treatment Surgery
  • 相关文献

参考文献8

二级参考文献22

共引文献49

同被引文献27

  • 1Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008 : GLOBOCAN 2008 [ J ]. Int J Cancer,2010,127 ( 12 ) : 2893-2917.
  • 2Wislez M, Massiani MA, Milleron B, et al. Clinical characteristics of pneumonic-type adenocarcinoma of the lung [ J ]. Chest, 2003, 123 (6) :1868-1877.
  • 3Epaulard O, Moro D, Langin T, et al. Bronchorrhea revealing cervix ad- enocarcinoma metastastic to the lung [ J ]. Lung Cancer, 2001,31 ( 2- 3) :331-334.
  • 4Algln O, Gokalp G, Topal U. Signs in chest imaging [J].Diagn Interv Radio1,2011,17 ( 1 ) : 18-29.
  • 5Kris MG, Giaccone G, Davies A, et al. Systemic therapy of bronchio- loalveolar carcinoma:results of the first IASLC/ASCO consensus con- ference on bronchioloalveolar carcinoma[ J]. J Thorac Onco1,2006,1 (9 Suppl) :S32-S36.
  • 6Yamakawa H, Takayanagi N, Ishiguro T, et al. A favorable response to cisplatin,pemetrexed and bevacizumab in two cases of invasive mu- cinous adenocarcinoma formerly known as pneumonic-type mucinous bronchioloalveolar carcinoma [J]. Intern Med, 2013,52 ( 24 ) : 2781- 2784.
  • 7Wu YL, Fukuoka M, Mok TS, et al. Tumor response and health relat- ed quality of life in clinically selected patients from Asia with ad- vanced non-small-ceU lung cancer treated with first-hne gefitinib : Post hoc analyses from the IPASS study[ J]. Lung Cancer,2013,81 (2) :280-287.
  • 8Svoboda M, Fabian P, Slaby O, et al. EGFR tyrosine kinase inhibitors as a targeted therapy for bronchioloalveolar carcinoma of the lung: a case report of a clinically prompt and intensive response and literature review [ J ]. Klin Onko1,2010,23 (4) :224-230.
  • 9West HL, Franklin WA, McCoy J, et al. Gefitinib therapy in advanced bronehioloalveolar carcinoma: Southwest Oncology Group Study S0126 [ J ]. J Clin Oncol,2006,24 (2) : 1807-1813.
  • 10骆宝建,吕平欣,周新华,潘纪戍.46例炎症型肺癌CT影像分析[J].中华肿瘤杂志,2007,29(11):860-863. 被引量:27

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部